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Abstract
Until recently, microbial identification in clinical diagnostic laboratories has
mainly relied on conventional phenotypic and gene sequencing identification
techniques. The development of matrix-assisted laser desorption ionization
time-of-flight mass spectrometry (MALDI-TOF MS) devices has revolutionized
the routine identification of microorganisms in clinical microbiology laborato-
ries by introducing an easy, rapid, high throughput, low-cost, and efficient
identification technique. This technology has been adapted to the constraint of
clinical diagnostic laboratories and has the potential to replace and/or
complement conventional identification techniques for both bacterial and
fungal strains. Using standardized procedures, the resolution of MALDI-TOF
MS allows accurate identification at the species level of most Gram-positive
and Gram-negative bacterial strains with the exception of a few difficult strains
that require more attention and further development of the method. Similarly,
the routine identification by MALDI-TOF MS of yeast isolates is reliable and
much quicker than conventional techniques. Recent studies have shown that
MALDI-TOF MS has also the potential to accurately identify filamentous fungi
and dermatophytes, providing that specific standardized procedures are
established for these microorganisms. Moreover, MALDI-TOF MS has been
used successfully for microbial typing and identification at the subspecies level,
demonstrating that this technology is a potential efficient tool for epidemiolog-
ical studies and for taxonomical classification.
Introduction
The matrix-assisted laser desorption ionization time-of-
flight mass spectrometry (MALDI-TOF MS) is a rapid,
accurate, and cost-effective method of microbial charac-
terization and identification. This technology generates
characteristic mass spectral fingerprints, that are unique
signatures for each microorganism and are thus ideal for
an accurate microbial identification at the genus and
species levels and has a potential to be used for strain
typing and identification.
MS has been used for several decades in chemistry but
it was in 1975 that Anhalt and Fenselau (Anhalt & Fense-
lau, 1975) proposed for the first time that bacterial char-
acterization could be achieved using this technique. They
noticed that unique mass spectra were produced from
bacterial extracts of different genera and of different spe-
cies. In the 1980s, the development of desorption/ioniza-
tion techniques such as plasma desorption (PD), laser
desorption (LD) and fast atom bombardment (FAB)
allowed the generation of molecular biomarker ions from
microorganisms leading to bacterial profiling (Heller
et al., 1987; Platt et al., 1988). In early experiments, only
biomarker molecules of low molecular masses such as
bacterial lipids were analysed (Shah & Collins, 1980; Hel-
ler et al., 1988), as the processes used for the ionization
of biomolecules were too energy rich to avoid unpredict-
able analyte decomposition. The evolution of soft ioniza-
tion techniques such as MALDI and electrospray
ionization (ESI) developed in the late 1980s (Tanaka &
Fenn, 2002) made possible analysis by MS of large bio-
molecules such as intact proteins. Several groups (Cain
et al., 1994; Girault et al., 1996; Liang et al., 1996) dem-
onstrated that MALDI-TOF could be used to produce
protein profiles following cellular extraction and purifica-
tion. However, Holland et al. (1996) reported for the first
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time in 1996 that MALDI-TOF spectral fingerprints could
be obtained from whole bacterial cells without pretreat-
ment before the MS analysis. This approach was then
used to identify bacteria at the genus and species levels by
multiple research teams (Claydon et al., 1996; Krishna-
murthy & Ross, 1996; Haag et al., 1998; Pribil & Fense-
lau, 2005; Pignone et al., 2006; Vargha et al., 2006; Nagy
et al., 2009). Since the late 1990s, the success of this
technique for the rapid identification of bacteria but also
fungi and yeast was demonstrated by an impressive expo-
nential increase in the number of publications concerning
MALDI-TOF identification of microorganisms.
MALDI-TOF MS has been used to characterize a
wide variety of microorganisms including bacteria, fungi,
and viruses (Giebel et al., 2010). The capability of MALDI-
TOF to rapidly characterize microorganisms favors its
potential applications in multiple areas including medical
diagnostics, biodefense, environmental monitoring, and
food quality control. MALDI-TOF MS is suitable for
high-throughput and rapid microbial identification at low
costs and is an alternative for conventional laboratory
biochemical and molecular identification systems.
In this review, we will first present the technical back-
ground of the MALDI-TOF MS method including sample
preparation, MS, bioinformatics analysis of fingerprint
spectra, and their comparison with databases for microor-
ganism identification. We will then present the applica-
tion of MALDI-TOF MS microbial identification from
bacteria and fungi isolates and directly from clinical sam-
ples. We will then address the important issues of quality
control, maintenance, time-to results, and cost effective-
ness. Finally, we will discuss the use of MALDI-TOF MS
for additional applications such as microbial taxonomy,
typing and identification of virulence factors (Bizzini &
Greub, 2010; Murray, 2010).
Technique
A mass spectrometer is composed of three functional
units, (1) an ion source to ionize and transfer sample
molecules ions into a gas phase, (2) a mass analyser that
separate ions according to their mass-to-charge ratio (m/z),
and (3) a detection device to monitor separated ions.
Several ionization methods have been developed including
PD, FAB, chemical ionization (CI), atmospheric pressure
CI, electrospray (ESI), LD, and MALDI. The method of
ionization is determined according to the nature of the
sample and the goal of the MS analysis, but ESI and
MALDI are soft ionization techniques that allow ioniza-
tion and vaporization of large nonvolatile biomolecules
such as intact proteins (Emonet et al., 2010). In contrast
to ESI, MALDI generates mostly singly charged ions and
thus MALDI derived spectra may include larger numbers
of proteins. LD has been successfully coupled to several
kinds of mass analysers to characterize microorganisms
such as TOF (Lay, 2001), Fourier transform ion cyclotron
resonance (Ho & Fenselau, 1998), quadrupole-TOF (She
et al., 2001), and quadrupole ion trap (Meetani et al.,
2007). The various operative modes of the different mass
analysers confer strengths and weaknesses in their perfor-
mance characterized by mass accuracy, resolution, mass
range, sensitivity, and scan speed and cost (Table S1)
(Jonsson, 2001; Aebersold & Mann, 2003; Domon &
Aebersold, 2006; Graham et al., 2007). The performance
of mass analysers can be improved by combining and/or
summing the advantages of one sort of analyser (tandem
MS) or of different analysers (hybrid MS) through the
development of multistage instruments such as hybrid
quadrupole TOF (Q-Q-TOF), tandem TOF (TOF-TOF),
and triple quadrupole (Domon & Aebersold, 2006). Over-
all, the required performance expected form a mass analy-
ser depends on the type of sample to be analysed
(complex/simple mixtures, proteins, peptides, lipids, and
polysaccharides) and the ultimate goal of the analysis
(quantification, protein identification, microorganism
identification, and biotyping).
TOF mass analysers (Cotter, 1997) have been used for
intact microorganisms detection for many years (Heller
et al., 1987), because they are suited for interfacing with
pulse laser ionization and offer the possibility of rapid
analysis and miniaturization.
In MALDI analysis, samples are prepared by mixing
the samples with a matrix which results in the crystalliza-
tion of the sample within the matrix. The matrix is
composed of small acid molecules that have a strong
optical absorption in the range of the laser wavelength
used. The matrix composition varies according to the
biomolecule to be analysed and the type of laser used
(Fenselau & Demirev, 2001). The most frequently used
matrices are 2,5-dihydroxybenzoic acid (DHB), a-cyano-
4-hydroxycinnamic acid (CHCA), sinapinic acid (SA),
ferulic acid (FA), and 2,4-hydroxy-phenyl benzoic acid.
FA, SA, and CHCA have been shown to be effective for
the detection of proteins biomarkers (Fenselau & Demi-
rev, 2001; Vaidyanathan et al., 2002; Williams et al.,
2003), whereas DHB appears to be the best choice for the
detection of glycopeptides and glycoproteins (Giebel
et al., 2010). The size and the intensities of the peaks of
the detected molecules are dependent on the matrix
selected for the experiment. DHB and CHCA are usually
optimal for the detection of lower mass ions (Hathout
et al., 2000; Williams et al., 2003; Ruelle et al., 2004) with
a detection up to 10 kDa when the proper solvent is
used. Both SA and FA have been shown to be better for
the detection of higher mass ions (above 15 kDa)
(Madonna et al., 2000; Conway et al., 2001; Ruelle et al.,
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2004; Vargha et al., 2006) but provide a lower sensitivity
than CHCA (Wang et al., 1998; Ruelle et al., 2004).
Intact microorganisms can be directly processed to
MALDI-TOF without pretreatment because most vegeta-
tive bacteria are lysed following exposure to water, organic
solvent and/or strong acid in the MALDI matrix. When
resistant microrganims such as some viruses, bacterial
spores, and yeast cells have to be analysed by MALDI,
strong organic acids and/or alcohols are usually added in
pretreatment steps. Similarly, for some bacterial species
(such as the Actinomyces), specific pretreatment or pro-
tein extraction procedures may be useful (Bizzini et al.,
2011).
The marked differences in bioanalytes fingerprints
observed with the different matrix demonstrate that simi-
lar standardized preanalytical and analytical procedures
than those performed to establish a database must be fol-
lowed to ensure accurate identification. This implies that
any modification of the procedure (1) should conformed
to the manufacturer’s recommendations, (2) should be
analysed to demonstrate that protein profiles remained
consistent with database fingerprints or (3) should use a
new database created with the modified protocol.
In practice, a microbial sample is mixed with a matrix
on a conductive metal plate. The mixture can be depos-
ited on the metal support or alternatively the microbial
sample is deposited and dried out on the support before
the addition of the matrix. After the crystallization of the
matrix and compound, the target on the metal plate is
introduced in the mass spectrometer where it is bom-
barded with brief laser pulses from usually a nitrogen
laser (Fig. 1). The matrix absorbs energy from the laser
leading to the desorption of the analytes that are then
vaporized and ionized in the gas phase. This matrix-
assisted desorption and ionization of the analytes leads to
the formation of predominantly singly charged sample
ions. The desorbed and ionized molecules are first accel-
erated through an electrostatic field and are then ejected
through a metal flight tube that is subjected to a vacuum
until they reach a detector, with smaller ions traveling
faster than larger ions. The TOF required to reach the
detector is dependent on the mass (m) and charge (z) of
the bioanalyte and is proportional to the square root of
m/z. Thus, bioanalytes with different m/z that composed
a complex sample are separated according to their TOF
and create a mass spectrum that is characterized by both
the m/z and the intensity of the ions, which is the num-
ber of ions of a particular m/z that struck the detector.
The results of a spectral signature is composed of spikes
ranging usually from 1000 to 20 000 m/z. Usually,
MALDI produces single charged (z = 1) ions and thus
the m/z of an analyte corresponds to the value of its
mass.
Data analysis
Biomarkers
Several research groups have demonstrated that biomole-
cules desorbed from whole unfractionated cells and
detected above 4 kDa are intact proteins (Arnold et al.,
1999; Dai et al., 1999; Holland et al., 1999; Ryzhov &
Fenselau, 2001). Most of the biomarkers detected in
MALDI-TOF spectra of intact bacterial cells have a
molecular mass below 15 kDa. A thorough characteriza-
tion of MALDI biomarkers performed on intact Escheri-
chia coli cells have demonstrated that the MALDI
detected biomolecules corresponds to proteins from the
inside of bacterial cell that are abundant, basic, and of
medium hydrophobicity (Ryzhov & Fenselau, 2001).
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Fig. 1. Technical description of MALDI-TOF MS. The sample is mixed
with a matrix on a conductive metal plate. After crystallization of the
matrix and microbial material, the metal plate is introduced in
the mass spectrometer and is bombarded with brief laser pulses. The
desorbed and ionized molecules are accelerated through an
electrostatic field and ejected through a metal flight tube subjected to
vacuum until they reach a detector, with smaller ions traveling faster
than larger ions. Thus, bioanalytes separated according to their TOF
create a mass spectrum that is composed by mass to charge ratio
(m/z) peaks with varying intensities. A spectrum is thus a microbial
signature that is compared with a database for the identification at
the species or genus level.
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Among these MALDI-detected proteins, about half
matched ribosomal proteins that are abundant and very
basic (Arnold et al., 1999; Ryzhov & Fenselau, 2001),
which is a biochemical trait favorable for efficient ioniza-
tion during the MALDI process (Krause et al., 1999).
Thus, the abundance (more than 20% of total cell pro-
teins) and the basic nature of ribosomal proteins explain
why the majority of the peaks detected in a MALDI-TOF
spectrum correspond to ribosomal proteins. In addition,
the lysis of bacterial cells in organic solvents and in acidic
conditions favoring the extraction of ribosomal proteins
combined with the utilization of a specific matrix allowed
the development of a method leading to the ionization of
mainly ribosomal proteins (Suh & Limbach, 2004).
In a study performed by Ryzhov & Fenselau (2001) on
E. coli to characterize the nature of the proteins favored
by MALDI, several additional groups of proteins than
ribosomal proteins were identified. These also included
abundant nucleic acid-binding proteins, such as E. coli
DNA-binding protein HU a- and b-subunits (DbhA and
DbhB, respectively) and cold-shock proteins, such as
cold-shock proteins A, C, and E (CspA, CspC, and CspE).
Similar to ribosomal proteins, these protein families are
highly abundant, basic, and of medium hydrophobicity.
Holland et al. (1999) potentially identified the acid-resis-
tant precursor proteins HdeA and HdeB observed in the
MALDI analysis of both intact E. coli and Shigella flexneri.
The ion at m/z 7643 in the spectra from Pseudomonas
aeruginosa was mapped to the cold-shock protein CspA
and similarly the ion at m/z 7684 observed in Pseudomo-
nas putida was identified as the cold-acclimation protein
CapB (Fenselau & Demirev, 2001). Sun et al. (2006) have
selected in the MALDI-TOF spectra of Lactobacillus plan-
tarum 34 reliable biomarkers including 31 ribosomal sub-
unit proteins and three ribosome-associated proteins
identified as a small heat shock protein, a methylase and
the DNA-binding protein II. A comprehensive study was
published by Dieckmann et al. (2008) where protein
identities were assigned to biomarker peaks obtained by
whole-cell MALDI-TOF MS of salmonellae. Most of the
proteins identified in this study were abundant cytosolic
proteins that were highly basic including in particular
ribosomal proteins, proteins involved in DNA or RNA
binding, and other abundant proteins, most of which
have a high isoelectric point > 9. Thus, examples of bio-
marker peaks assigned to proteins characterized by a high
isoelectric point included not only ribosomal proteins but
also many other proteins such as cold shock-like protein
CspH, translation initiation factor IF-1 (pI 9.23), DNA
binding protein HU a- and b- (pI 9.69 and 9.57), the
ribosome modulation factor (pI 10.56), and integration
host factors A and B (both pI 9.34). Lower pI value pro-
teins detected in this study were in general very abundant
proteins including the nucleoid-associated protein H-NS
(pI 5.32), the RNA chaperone CspE (pI 8.08), glutared-
oxin-1 (pI 5.63), and the phosphocarrier protein HPr
(pI 5.6).
Thus, most of MALDI-TOF spectra are composed of
very conserved proteins with house-keeping functions
affected to a minimal extent by environmental conditions
and thus considered to be optimal for routine identifica-
tion of bacteria.
Biomarkers reproducibility
The reproducibility of MALDI-TOF spectrum of whole
bacterial sample is problematic as large variations can be
seen in spectra of the same bacterial species obtained in
different conditions. Many experimental parameters can
have an important effect on the observed mass spectra
(Wang et al., 1998). The reproducibility is dependent on
the MALDI-TOF instrument, the matrix used, the age of
the microorganism, the sample : matrix ratio, the sample
concentration, the culture medium and growth conditions
(Valentine et al., 2005). However, several studies have
shown that a subset of peaks from genetically identical
bacteria was conserved in spectra obtained in different
experimental conditions (Wang et al., 1998; Welham
et al., 1998). These conserved peaks, among which ribo-
somal proteins are well represented, explain the feasibility
to use MALDI-TOF for bacterial identification even with-
out the standardization of experimental conditions. These
results also suggest that selected specific conserved bio-
marker proteins could be used for bacterial identification
irrespective of changes in other biomarkers. However, to
optimize the reproducibility, a standardization of sample
preparation (e.g. choice of matrix, concentrations, solvent
and crystallization conditions) has to be established by
diagnostic laboratories.
Intra-laboratory reproducibility
Only a few studies have reported investigations on intra-
laboratory reproducibility. In two studies that were
focusing only on the presence or absence of particular
peaks but not on peak intensities, the level or reproduc-
ibility obtained was equal to 75% or higher using the
same mass spectrometer and similar sample preparation
techniques (Saenz et al., 1999; Walker et al., 2002). The
reproducibility of MALDI-TOF MS fingerprints was high
even when mass spectra were obtained from bacterial
cultures propagated in the same standard culture condi-
tions during weeks and even months (Bernardo et al.,
2002).
In our laboratory, we observed that the reproducibility
is mainly dependent on the quality of the deposit and
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that the extraction step is not associated with significant
supplementary variability. Thus, when considering the
higher peaks ( 200 intensity units) obtained with
E. coli strain ATCC 25922 in 10 independent analyses, 66
peaks were present in all 10 replicates performed with
proteins obtained from the same extraction whereas 78
peaks were present in the 10 spectra obtained from 10
independent extractions (Fig. 2a). Similar results were
obtained with Staphylococcus aureus strain ATCC 25923
(Fig. 2b).
Inter-laboratory reproducibility
The variation of inter-laboratory reproducibility is not sur-
prisingly much higher as small variation in sample prepa-
ration and analysis may significantly affect mass
fingerprints. Unfortunately, only a few attempts have been
made to compare results from different laboratories on the
same organism (Mellmann et al., 2009). In addition, inter-
laboratory studies based on different comparative settings
have been performed and gave very different results. Stud-
ies comparing mass spectra of identical microorganisms
obtained in different locations but with the same experi-
mental protocols and instruments hardware and software
have shown promising results in terms of inter-laboratory
reproducibility. For instance, two studies using different
bacterial species have demonstrated that more than 60%
of the peaks observed in mass spectra were similar in sepa-
rate laboratories (Wang et al., 1998; Walker et al., 2002).
However, a poor inter-laboratory reproducibility of
MALDI-TOF MS of intact microorganisms was demon-
strated in a study where three independent laboratories
using three different commercial instruments performed a
MALDI-TOF MS analysis of identical aliquots of E. coli
culture prepared and analysed in the same experimental
conditions (Wunschel et al., 2005). In this study, only
25% of the biomarkers were found in common by all three
laboratories and more than 50% of the peaks were
detected in spectra from only one of the three laboratory.
Of importance, when the mass spectra collected from the
instrument of one of the laboratory was analysed in the
other two laboratories, 70% of the mass fingerprints could
be identified correctly as E. coli. This finding underlines
the importance of the instrument in the establishment of
bacterial fingerprint databases.
Application for microorganism identifications
Two general MALDI-TOF MS methods have been pro-
posed to characterize microorganisms: (1) mass spectra
comparison with fingerprints database and (2) matching
of biomarker masses to a proteome database (see Box S1).
In the first approach, generated unique spectra of intact
cells are compared with previously collected fingerprint
libraries that are commercially available. This solution is
rapid, simple, and is easily adaptable for routine use in
diagnostic laboratories. This approach is convenient to
develop specific databases constituted of unique and con-
served peaks that can be used for species and subspecies
identification, independently of the culture conditions
used to grow the microorganism (Carbonnelle et al.,
2007). In the second approach, the biomarker masses
associated with an unknown microorganism are identified
by matching protein molecular masses in the spectrum
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Fig. 2. Intra-laboratory reproducibility tested by measuring the
number of conserved peaks in two experimental settings. In the first
setting, ethanol/formic acid extraction was applied on Escherichia coli
ATCC 25922 (a) or Staphylococcus aureus ATCC 25923 (b) and 10
replicates of one extraction were spotted onto the MALDI-TOF
microplate (1 lL, about 106 bacteria lL1). In the second setting, 10
independent extractions were performed and one replicate of each
extraction was spotted onto the MALDI-TOF microplate. After
smoothing and baseline subtraction, the 100 highest peaks from each
spot were selected and the number of time a given peak is present
out of 10 times was determined for each peak in the two different
settings for Escherichia coli and Staphylococcus aureus.
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with protein molecular masses predicted from sequenced
genomes (Demirev et al., 1999). This method is based on
the observation that the majority of observed biomole-
cules above 4000 m/z in MALDI-TOF spectra of whole
cell extracts are proteins. An available algorithm predicts
protein masses in silico from the genomes and seeks
matches with experimentally derived masses (Pineda
et al., 2000). However, this application is limited to
microorganisms whose genomes are sequenced and fur-
ther development in strategies for organization of the
proteome database is required. The advantage of such a
bioinformatics-based approach compared with bacterial
fingerprinting is that the identification tolerates variations
in the protein profiles and thus differences in culture
growth and sample treatment conditions.
Bacterial identification
The identification of microorganisms in clinical diagnos-
tic microbiology laboratories is nowadays mainly per-
formed by analysis of biochemical reactions and
phenotypic characteristics, such as growth on different
media, colony morphology and Gram staining. When
combined, these routine laboratory techniques ensure an
accurate identification of most microorganisms but are
costly, require time, and need in some cases well-trained
technician for correct interpretation. One of the major
advantages of using MALDI-TOF technology for bacte-
rial identification is the time-to-result, which is reduced
from 24 to 48 h to less than an hour. In addition,
MALDI-TOF allowed accurate bacterial identification of
a large variety of bacteria, that only exhibit few pheno-
typic traits and that were identified by 16S rRNA gene
sequencing prior to the MALDI-TOF era (Bizzini et al.,
2011).
Routine identification
Several approaches are commonly used in routine diag-
nostic laboratories. One typical approach is to pick bacte-
rial isolates colonies freshly grown on defined agar
medium with a sterile tip and to smear a thin film onto a
ground steel MALDI target plate. The microbial film is
then overlaid with a MALDI matrix selected as recom-
mended by the MALDI-TOF manufacturers, typically
1.5 lL CHCA in 50% acetonitrile/2.5% trifluoroacetic
acid for the Bruker instrument and 0.5 lL of 20 mg
DHB dissolved in 1 mL water-ethanol-acetonitrile
[1 : 1 : 1] mix for the Shimadzu instrument. In our labo-
ratory, to increase identification yield, we routinely add
formic acid on smeared microorganisms before adding
the matrix. The sample-matrix mixture is dried at room
temperature and then introduced in the MALDI-TOF
instrument for data acquisition. The data are processed
by the associated softwares (see above) and the spectra
are compared with reference libraries for bacterial identi-
fication. A protein extraction step using ethanol-acetoni-
trile is performed when direct application procedure
failed.
Several studies have analysed the bacterial identification
efficiency of these two instruments (Bruker and Shima-
dzu) with their respective software and databases
(Table 1). We will present here the results of (1) two
intra-laboratory studies using the Bruker system (Seng
et al., 2009; van Veen et al., 2010), (2) an intra-laboratory
study evaluating the two instruments using the same
microbial samples (Cherkaoui et al., 2010), and (3) a
large international interlaboratory study performed with
the Bruker instrument (Mellmann et al., 2009).
Using the Bruker system, 327 clinical isolates previously
identified by conventional techniques were analysed using
MALDI-TOF MS by van Veen et al. (2010). The authors
observed a 95.1% correct identification at the genus level
and a 85.6% at the species level. The same group per-
formed a prospective validation study on 980 clinical iso-
lates of bacteria and yeast that showed a 92.2% correct
identification by MALDI-TOF, a performance signifi-
cantly better than the 83.1% identification obtained with
conventional biochemical systems. Correct species identi-
fication by MADLI-TOF MS was observed in 97.7% of
Enterobacteriaceae, 92% of nonfermentative Gram-nega-
tive bacteria, 94.3% of staphylococci, 84.8% of strepto-
cocci, 84% of bacteria of the HACCEK group
(Haemophilus, Actinobacillus, Cardiobacterium, Capnocy-
tophaga, Eikenella, and Kingella) and 85.2% of yeasts. In
this work, misidentification was clearly associated with
insufficient spectra from suitable reference strains in the
reference spectra database.
Seng et al. (2009) have conducted a prospective routine
MALDI-TOF MS identification analysis with the Bruker
system on 1660 bacterial isolates in parallel with conven-
tional phenotypic bacterial identification. Discrepancies
were resolved by 16S rRNA and rpoB gene sequencing.
They have shown that 95.4% of the isolates were correctly
identified using MALDI-TOF MS among which 84.1% at
the species level and 11.3% at the genus level only.
Absence of identification (2.8% of isolates) and incorrect
identification (1.7% of isolates) were mainly due to
improper database entries. They have estimated that the
MALDI-TOF identification required an average time of
6 min for an estimated 70–80% reduced cost compared
with conventional methods of identification.
Cherkaoui et al. (2010) have evaluated the two main
MALDI-TOF MS systems, Bruker and Shimatzu, in a
comparative study with 720 bacterial isolates under rou-
tine clinical laboratory conditions. The isolates were
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Table 1. Performance of routine identification by MALDI-TOF MS
References N Description
Genus level
(%)
Species
level (%)
Mis-
identification
(%) No ID (%) Comments
van Veen
et al.
(2010)
327 Total 95.1 85.6 3 3.9 Retrospective intra-laboratory
study
Misidentification: associated
with absence or mislabeling
of reference spectra in
the database
89 Enterobacteriaceae 100 96.6 3.4 0
55 Non-fermentative GN 81.8 74.5 5.4 14.5
87 GP cocci 97.7 80.5 1.1 2.3
77 Miscellaneous bacteria
(HACCEK)
94.8 84.4 3.9 1.3
19 Yeasts 100 94.7 0 0
van Veen
et al.
(2010)
980 Total 98.8 92 1.7 1.1 Prospective intra-laboratory
study
Misidentification: associated
with absence or mislabeling
of reference spectra in
the database
Viridans streptococci and
pneumococci characterized
by many misidentifications
Weakness of the study:
lack of sufficient
anaerobic bacteria and
GP aerobic rods included
in the tested samples
311 Enterobacteriaceae 100 97.7 0.3 0
88 Non-fermentative GN 94.3 92 1.1 4.6
261 GP cocci in cluster 100 94.3 0.4 0
165 GP cocci in chains 98.8 84.8 7.3 1.2
Enterococci 100 98.4 0 0
Hemolytic
streptococci
100 100 0 0
Streptococcus
milleri group
100 77.8 0 0
Pneumococci 100 86.4 0 0
Viridans
streptococci
90.5 9.5 57.1 9.5
94 Miscellaneous bacteria
(HACCEK)
96.8 84 0 3.2
61 Yeasts 96.7 85.2 3.3 3.2
Seng et al.
(2009)
1660 Total 95.4 84.1 1.7 2.8 Prospective intra-laboratory
study
Lack of identification mainly
for non-Clostridium
anaerobes due to an
absence of reference spectra
in the database
ND GP 0.8 2
ND GN 0.9 0.7
Cherkaoui
et al.
(2010)
720 Total 100 94*/89† 0.9*/0.5† Comparative intra-laboratory
study of two commercial
MALDI-TOF MS devices
(Bruker and Shimatzu)
Poor yield for streptococcal
species and for GN
anaerobes (< 50% correct
identification)
416 Enterobacteriaceae 99.8*/95.9† 0*/0†
80 Aerobic GN 97.5*/96.3† 1.25*/0†
111 Staphylococci 98.2*/96.4† 0.9*/0.9†
87 Aerobic GP 73.6*/55.2† 3.4*/2.3†
6 Anaerobic GN 17*/0† 0*/0†
7 Anaerobic GP 57*/43† 25*/0†
Mellmann
et al.
(2009)
480 Total 98.7 1.04 0.2 Interlaboratory study
60 non-fermenting bacteria
were shipped to 8 different
laboratories with access to
Bruker platforms
No significant difference
between direct application
and preprocessed samples
Misidentification:
sample interchange (4)
and skin contamination (1)
60 Laboratory A 100 0 0
60 Laboratory B 96.67 1.7 1.7
60 Laboratory C 100 0 0
60 Laboratory D 93.33 6.66 0
60 Laboratory E 100 0 0
60 Laboratory F 100 0 0
60 Laboratory G 100 0 0
60 Laboratory H 100 0 0
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analysed in parallel on both devices according to the
manufacturers’ default recommendations. The MALDI-
TOF MS results were compared with conventional bio-
chemical identification tests and discordant results were
resolved with 16S rRNA gene sequencing. The Bruker MS
system gave high-confidence identification for 680 of 720
isolates (94.4%) whereas the Shimadzu MS showed a
high-confidence identification for 639 isolates (88.8%).
These results showed also that only 6/680 (0.9%) of the
Bruker and 3/639 (0.5%) of the Shimadzu identifications
gave an incorrect high-confidence identification at the
species level. All the high-confidence MS identifications
were accurate at the genus level. In addition, the Bruker
MS system has identified 9 (69%) and the Shimadzu sys-
tem 5 (38%) of 13 isolates that were not identified by con-
ventional phenotyping methods.
Interlaboratory species identification was assessed in a
large international multicenter study (Mellmann et al.,
Table 1. Continued.
References N Description
Genus level
(%)
Species
level (%)
Mis-
identification
(%) No ID (%) Comments
Bizzini
et al.
(2010)
1371 Total direct application 70.3 Intra-laboratory study
Protein extraction increases
the total yield of valid
results by 25% compared
with direct application
Misidentification: inaccurate
taxonomic assignment,
change in the taxonomy,
limit of resolution of the
method
1371 Total protein extraction 95.4 92.6 4.2 4.6
525 GP direct application 73.7
525 GP protein extraction 99.6 98.85 0.95 0.4
729 GN direct application 71.6
729 GN protein extraction 97 92.2 7 3
24 Yeasts direct application 4.1
24 Yeasts protein
extraction
100 100 0 0
Marklein
et al.
(2009)
267 Total before
complementation
of database
92.5 7.5 Intra-laboratory study of
clinical yeast isolates
[Candida (n = 250),
Cryptococcus,
Saccharomyces,
Trichosporon, Geotrichum,
Pichia and
Blastoschizomyces spp.]
All isolates identified upon
complementation of the
database with appropriate
reference strains
All samples were
preprocessed with a protein
extraction step before
deposition
267 Total after
complementation
of the database
100 0
Bader
et al.
(2010)
1192 Total 97.6*/96.1† 0.7*/0.2† 1.7*/3.7† Comparative intra-laboratory
study of two commercial
MALDI-TOF MS devices
(Bruker and Shimatzu) on
clinical yeast isolates
Better yield observed when
the performance is only
tested on species present
in respective databases
All sample were
preprocessed with a protein
extraction step before
deposition
1175*/1152† Challenged
against
respective database
99*/99.4† 0.5*/0† 0.5*/0.6†
Genus and species level (%), percent of identification at the genus and species level respectively. Misidentification (%), percent of misidentified
samples. No ID (%), percent of samples not identified. *Bruker system, †Shimatzu.
N, sample number; GP, Gram-positive; GN, Gram-negative.
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2009) using the Bruker system. In this study, eight partici-
pating laboratories received 60 blind-coded samples for
MALDI-TOF MS species identification and 98.75% were
correctly identified at the species level. Six of the eight labo-
ratories identified all 60 samples correctly. Out of a total of
480 samples, six samples were misidentified and one sam-
ple did not give any valid result due to low signal intensity.
Thus, in contrast to other studies (Wang et al., 1998), the
utilization of a commercial system developed for routine
use provided high reliability for bacterial identification.
Although excellent results have been shown for bacte-
rial identification by MALDI-TOF MS, both the diagnos-
tic yield (identification at the genus, species or strain
level) and the accuracy of identification depends on the
taxonomy and in the quality of the databases. As shown
by many studies, most of the bacterial groups including
Enterobacteriaceae, nonfermentative Gram-negative bacte-
ria, staphylococci, and hemolytic streptococci were cor-
rectly identified as the species level (Seng et al., 2009;
Cherkaoui et al., 2010; van Veen et al., 2010). Regarding
staphylococci, the MALDI-TOF MS has brought up an
important advantage by allowing rapid and simplified
identification of both S. aureus and of some species
belonging to coagulase-negative staphylococci (CoNS).
Unlike most commercial identification systems that allow
a rapid identification of only S. aureus, the MALDI-TOF
MS allows a correct identification of various CoNS spe-
cies (Speers et al., 1998; Bernardo et al., 2002; Dupont
et al., 2010). In a comparative study between MALDI-
TOF MS and two rapid identification automated systems,
BD Phoenix (BD Diagnostic Systems, France) and Vitek-2
(bioMe´rieux, Marcy l’Etoile, France), the identification of
234 CoNS belonging to 20 different species showed that
the MALDI-TOF performance was significantly better
(93.2%) than Phoenix (75.6%) and Vitek-2 performance
(75.2%) (Dupont et al., 2010). Overall, MALDI-TOF
appears to be excellent at identifying various staphylococci
species as demonstrated by the congruence of 99.3% (444/
447) between MALDI-TOF and rpoB sequence-based
identifications (Spanu et al., 2011). As CoNS can cause
serious infections and are frequently associated with hospi-
tal-acquired infections, the rapid identification at the
species level by MALDI-TOF is very useful in distinguish-
ing clinically significant CoNS from contaminant strains
(von Eiff et al., 2002).
Problematic identifications
Most of the problematic identifications encountered in
most of the recent studies concerned the viridans strepto-
cocci group, the pneumococci and anaerobic bacteria
(Table 2). Viridans streptococci and pneumococci were
commonly misidentified mainly due to an incomplete
database reference library. In the study by Seng et al.
(2009), nearly 50% of Streptococcus pneumoniae isolates
were misidentified as Streptococcus parasanguinis [a close
Table 2. Problems commonly found in routine identification by MALDI-TOF MS
Problems Examples
Limit of resolution of the MALDI-TOF MS method Shigella spp. identified as E. coli
Database discordances
Errors in the reference spectra
Similarities of spectra present in the database*
Absence or insufficient reference spectra in the database*
Propionibacterium acnes wrongly identified as Eubacterium brachy
due to incorrect reference spectra in the database
Incomplete reference librairies for viridans streptococci and pneumococci
No reference of non-Clostridium anaerobes in the database
Insufficient number of reference spectra of Streptococcus
pneumoniae and Streptococcus parasanguinis in the database to differentiate
accurately these two closely related species
Only one spectrum of Propionibacterium acnes or Bacillus cereus present in
the database is not enough to be representative of the true diversity of
P. acnes and B. cereus profiles
Taxonomical discordances Stenotrophomonas maltophila misidentified as Pseudomonas hibiscicola,
which is an invalid name for S. maltophila
Agrobacterium tumefaciens is synonymous of Rhizobium rhizogenes
Insufficient protein signal
Difficult to lyse cell wall structures
Small amount of material sample
Yeasts require a protein extraction procedure to be correctly identified
Pneumococci as well as most strains of Haemophilus influenzae and
Klebsiella pneumoniae possess a capsule which prevents efficient lysis and
results to poor spectral quality
Actinomyces, Gemella, Nocardia, and Streptomyces species usually display
weak protein signals.
Better signal for Enterobacteriaceae grown on blood agar vs. MacConkey agar
*A higher number of reference spectra in the database are usually required to accurately identify closely related microorganisms that display a
high degree of spectrum similarities. Thus, these two parameters are interdependent.
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related species within the mitis group of Streptococcus
species (Kawamura et al., 1995)] because the database
contained only three S. pneumoniae and two S. parasan-
guinis reference spectra. The problem was solved by add-
ing additional S. pneumoniae isolates reference spectra to
the database which clearly indicates that the database
need to be updated with multiple spectra of well-charac-
terized streptococcal species. Until now, the identification
of Streptococcus spp. remains a problem for MALDI-TOF
MS identification especially for closely related species
such as S. pneumoniae, Streptococcus mitis, and S. paras-
anguinis. In the case of pneumococci, the use of MALDI-
TOF MS for identification is further impaired by the
weak extraction yield caused by the presence of a capsule.
Thus, identification of S. pneumoniae should not solely
rely on MALDI-TOF as false identification can results in
important clinical outcomes. In the study by Cherkaoui
et al. (2010), the diagnostic yield for streptococcal species
and for Gram-negative anaerobes was < 50% with an
accuracy of high-confidence species identification of only
57.1% for streptococci with the Bruker system and of
71.4% with the Shimadzu MS system.
To date, only a few studies have analysed the usefulness
of MALDI-TOF for routine identification of anaerobic
bacteria. Seng et al. (2009) showed that an improved data-
base is required as 50% of the total isolates (46) showing
no identification by MALDI-TOF MS were anaerobic bac-
teria including Fusobacterium nucleatum and non-Clostrid-
ium anaerobes that had no reference in the Bruker
database. In contrast, for anaerobic species (e.g. several
Bacteroides species) with sufficient spectra in the database,
the identification by MALDI-TOF MS was better com-
pared with that by conventional biochemical methods.
These fastidious organisms are poorly identified using
phenotypic methods with a lack of specificity and ambigu-
ous or false identification. There is thus an important
need to improve the database entries with additional
anaerobes isolates (Bessede et al., 2011).
Similar to other studies, Blondiaux et al. (2010) have
demonstrated the difficulties to identify viridans strepto-
cocci, pneumococci as well as HACCEK bacteria but also
Shigella and several strictly aerobic bacteria (Aeromonas
spp., Achromobacter spp., Alcaligenes spp.). In this study,
the mass spectra of six Shigella isolates were similar to
several E. coli strains present in the Biotyper database. In
another study, the misidentification of all Shigella sonnei
isolates with E. coli was also documented (Seng et al.,
2009).
Using 43 selected Mycobacteria strains, a mycobacterial
database could be engineered comprising species-specific
spectral profiles allowing identification of 44 species at the
species level and of nine strains of theMycobacterium absces-
sus complex and the Mycobacterium tuberculosis complex
at the mycobacterial clade level (Lotz et al., 2010). Under
the preanalytical and analytical conditions used in this
study, subspecies of the Mycobacterium abscessus complex
(Mycobacterium abscessus, Mycobacterium massiliense and
Mycobacterium bolletti) and the Mycobacterium tuberculosis
complex (Mycobacterium tuberculosis, Mycobacterium bo-
vis, Mycobacterium microti and Mycobacterium africanum)
produced indistinguishable mass profiles due to their high
degree of genetic similarity. Using this microbial database,
311 strains grown on solid medium were analysed using
MALDI-TOF MS allowing a 97% correct identification,
67% at the species level and 30% at the complex level,
respectively. No misidentification was observed. When
bacteria were grown on liquid media, correct identification
was reduced to 77%, likely due to a reduced number of
bacterial load or to potential interference with components
of the liquid media. Interestingly, the authors observed that
an increase in number of replicates (up to 5) did correlate
with an increase in the probability of good identification,
especially for slow-growing mycobacteria. Overall, several
studies demonstrate that MALDI-TOF MS provides high
reproducibility and specificity for mycobacterial identifica-
tion and represents an alternative to other time consuming
and fastidious conventional mycobacterial identification
methods (Hettick et al., 2004; Lefmann et al., 2004;
Pignone et al., 2006; Lotz et al., 2010).
In our study analysing the performance of MALDI-
TOF MS for the identification of 1371 bacterial isolates
routinely isolated in clinical microbiology laboratories
and characterized by conventional methods, 1278 (93.2%)
bacterial isolates were identified at the species level, 73
(5.3%) were only identified at the genus level and 20
(1.5%) gave no reliable identification (Bizzini et al.,
2010). Among the 1278 isolates identified at the species
level, 63 (4.9%) were misidentified. The majority of dis-
cordant results (42/63) were explained by discordances
due to the MALDI-TOF database, 14 were due to poor
discrimination of the spectra of closely related species
such as Shigella spp. and E. coli, and seven were caused
by errors in the initial conventional phenotypic and bio-
chemical identifications.
Many of the bacterial identifications that can be
peformed only at the genus level are due to incomplete
reference spectra covering many different isolates or spe-
cies from a given genus. For instance, only one reference
spectrum of Propionibacterium acnes (strain DSM 1897)
or Bacillus cereus are included in the Bruker database
which is totally insufficient to cover the true diversity
of these bacteria and thus to identify accurately these
microorganisms (Bizzini et al., 2010). In addition,
mislabelling of bacterial species in the database can cause
misidentification by MALDI-TOF MS. In the study by Seng
et al. (2009), seven Stenotrophomonas maltophilia isolates
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were incorrectly identified as Pseudomonas hibiscicola which
is an invalid name for a nonfermenting Gram-negative rod
that was demonstrated to be S. maltophilia.
These studies show that a complete and representative
database is an essential requirement for accurate identifica-
tion of isolates by MALDI-TOF MS. A frequent update of
the reference library database with spectra of appropriate
poorly represented reference strains by the manufacturers
but also by routine diagnostic laboratories can significantly
impact the MALDI-TOF identification performance.
Impact of sample preparation on MS
identification
Sample preparation has not been shown to be a major
issue for problematic identifications. Samples and matrix
prepared according to manufacturer’s instructions usually
guarantee high quality spectral fingerprints required for
efficient MALDI-TOF identifications. In most cases, the
composition of an appropriate matrix containing strong
solvent ensures efficient bacterial lysis required for
MALDI-TOF analysis. When invalid results are initially
obtained by MALDI-TOF MS following analysis of intact
bacteria directly deposited on MALDI target plate, a step
of bacterial protein extraction with acid-containing sam-
ple solvents improving cell lysis solves the problem in
most cases. Bizzini et al. (2010) have shown that a for-
mic acid-acetonitrile extraction step was required to get
a valid MALDI-TOF MS identification for 25.6% of the
1278 valid isolates. The yield of valid score from direct
application was almost the same, about 75%, for both
Gram-positive and Gram-negative bacteria. For instance,
the yields of valid scores without extraction step were equal
to 79% for S. aureus, 82% for Enterococcus faecalis, 92% for
P. aeruginosa, 74% for E. coli, 58% for Klebsiella pneumo-
niae and 58% for Staphylococcus epidermidis. However, the
authors concluded that protein extraction prior to
MALDI-TOF analysis should be performed only in particu-
lar cases known to be problematic such as colonies isolated
from urine culture devices and/or MacConkey agar which
contains crystal violet, a possible interfering substance
affecting mass peak signals. Indeed, the higher identifica-
tion rate obtained after an extraction step largely compen-
sates the longer hand-on-time associated with an
extraction procedure.
This was also demonstrated in a study performed by Liu
et al. (2007) who have developed a universal sample prep-
aration for characterization of bacteria by MALDI-TOF
MS. The protocol, consisting of a pretreatment of bacteria
with acidic sample solvents and mixing with CHCA or
5-chloro-2-mercaptobenzothiazole (CMBT) matrix, could be
used to analyse both Gram-positive bacteria, including
spore-producing B. anthracis and non-spore-producing
S. aureus, and Gram-negative bacteria such as Yersinia
pestis, E. coli, and Burkholderia cepacia that are character-
ized by high extracellular-polysaccharide contents.
However, for some microorganisms, insufficient cell
lysis and/or low quantity of sample material can be
problematic for efficient MALDI-TOF identification and
require the use of alternative identification approaches
such as 16S rRNA gene sequencing. A study by Bizzini
et al. (2011) focusing on the identification of 410 clinical
isolates that could not be identified with conventional
laboratory methods showed that 133/410 (32.4%) isolates
could not be either reliably identified with MALDI-TOF.
The failure to obtain a reliable identification was due to
the absence of reference spectra in the BioTyper database
for 58% (78/133) of the isolates and to poor protein
spectral signals for 41.4% (55/133) of the isolates. The
authors supposed that the poor spectrum quality
observed could be due to either the difficulty to lyse the
cell wall of some bacteria such as Gram-positive bacilli
and/or to fastidious growth of some isolate, which
yielded only small amount of available sample material.
Difficult to identify microorganisms belonging to the
genera Actinomyces, Gemella, Nocardia, and Streptomyces
could be observed in this study.
The rate of successful identification is directly linked to
the amount of microorganism available. We have
observed that the rate of correct identification is espe-
cially poor when the subculture has been incubated on a
plate for < 4 h (Fig. 3). Thus, when we tried to identify
various bacterial species isolated from positive blood cul-
tures and sub-cultured on agar, we observed that only
30% of bacteria could be successfully identified after 2 h
of incubation (Fig. 3c). This identification rate was signif-
icantly lower for Gram-positive cocci, remaining below
60% after 6 h. This is likely due to the amount of bacte-
ria available after short incubation period (Fig. 3b).
Indeed, using 10-fold dilutions of E. coli strain ATCC
25922 and S. aureus strain ATCC 25923, we could show
that as many as 106 bacteria per well were necessary to
consistently obtain a spectrum (Fig. 3a) ensuring a score
above 2 and that when the amount of bacteria was rang-
ing between 102 to 104 bacteria per well, the score was
always below 1.7 (data not shown). A lower amount of
bacteria may, however, be identified using a different
identification algorithm. Hsieh et al. (2008) have demon-
strated that as few as 5 9 103 cells from a pure strain can
be identified by MALDI-TOF MS using particular analysis
approaches based on selected markers (Hierarchical
Clustering Analysis and direct classification model
construction). Interestingly, using the classification model
analysis, the authors showed that successful MALDI-TOF
MS identification can also be achieved from a bacterial
species mixture consisting of as few as 3 9 104 cells. This
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study opens new perspectives for the direct identification
of low abundant bacteria located in mixed flora without
the prerequirement of bacterial isolation and culturing.
Fungal identification
Fungal identification still largely relies on phenotypic
traits. However, a few days are necessary to obtain mature
fungi with phyalids (phyalids are conidiogenous cells
observed in a type of fungal asexual reproduction leading
to the production of conidia). This time delay may be
important given the morbidity and mortality of fungal
infections, especially common and life threatening among
neutropenic patients. Thus, like PCR and sequencing,
MALDI-TOF has the potential to provide accurate and
objective identification at species level, with the additional
advantage of rapidity and reduced costs compared with
PCR and sequencing.
MALDI-TOF MS systems for the identification of micro-
organisms were successfully adapted for the identification of
fungi in the past 10 years. In 2000, Welham et al. were
among the first to perform fungal identification using the
MALDI-TOF MS approach (Welham et al., 2000). Three
fungal species, Penicillium spp., Scytalidium dimidiatum, and
Trychophyton rubrum, showed distinct spectral fingerprints
allowing accurate species distinction. Since then, many stud-
ies have demonstrated the usefulness of the MALDI-TOF
application for the identification of various fungal groups
such as penicillia, aspergilla, Fusarium, Trichoderma, and
dermatophytes. However, until now, MALDI-TOF MS is
mainly used for the routine identification of yeasts whereas
further development has to be accomplished in database
libraries and sample preparation protocols to implement
this identification approach to other group a of fungi such
as filamentous fungi and dermatophytes.
Yeasts
The databases of the associated softwares (Biotyper and
Saramis of the two main MALDI-TOF instruments con-
tains reference spectra of multiple clinical yeast isolates,
including several Candida spp. and Cryptococcus neofor-
mans, which allows the use of MALDI-TOF in routine
yeast laboratory identification (Table 1).
Marklein et al. (2009) evaluated MALDI-TOF MS for
the rapid routine identification of clinical yeast isolates
and showed that 92.5% (247/267) of clinical isolates of
Candida, Cryptococcus, Saccharomyces, Trichosporon, Geo-
trichum, Pichia, and Blastoschizomyces spp. were accu-
rately identified. In a study performed by van Veen et al.
(2010), 85% of 61 yeast isolates comprising 12 different
species were correctly identified without occurrence of
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Fig. 3. The amount of material is a critical factor for accurate
microbial identification by MALDI-TOF MS. (a) Spectral fingerprints
obtained from various quantities (106–103) of Escherichia coli ATCC
25922 grown on blood agar plates. The inoculums were prepared
from a sample with a turbidity of 4.0 McFarland that was diluted to
obtain the approximate quantity used for direct microplate deposition
(106–103 bacteria per spot). Protein extraction was performed by
directly mixing the samples with formic acid on microplate. The results
show that the quality of the spectrum and thus the performance of
identification are largely dependent on the sample amount spotted on
the microplate. (b) Growth of Staphylococcus epidermidis on blood
agar plates at 35 °C in 5% CO2 atmosphere after an incubation of 2,
4, 6, and 8 h, respectively. Usually, at least 6 h of incubation are
required to get sufficient amount of material to obtain an efficient
MALDI-TOF MS identification (c) Cumulative percentage of MALDI-TOF
identification obtained from Gram-negative [Escherichia coli (13),
Pseudomonas putida (2), Klebsiella pneumoniae (2), Enterobacter
cloacae (1)] and Gram-positive [Staphylococcus epidermidis (13),
Staphylococcus aureus (9), Streptococcus pyogenes (4), Streptococcus
pneumoniae (1), Staphylococcus hominis (1)] bacteria after short-time
plating on agar during 2, 4, 6, and 8 h, respectively. The number of
samples for each bacterial species analysed is indicated in brackets.
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major errors. Bizzini et al. (2010) achieved a 100%
correct identification of 24 yeast isolates belonging to 12
different species. The suitability of the two commercially
available MALDI-TOF MS systems, Bruker and Shima-
dzu, and their respective associated softwares and data-
bases, Biotyper and Saramis, was tested for rapid species
identification of yeasts in a clinical diagnostic approach
(Bader et al., 2010). Both MALDI-TOF MS systems have
showed a similar species identification rate of 97.6% for
Bruker/Biotyper and 96.1% for Shimadzu/Saramis that
were comparable with the biochemical tests rate (96.9%).
Based on isolates that were contained in the respective
database, no misclassifications were seen with Saramis
and fewer misidentifications were reported by the Biotyp-
er compared with classical approaches. Using the Bruker
MALDI-TOF system, Stevenson et al. (2010b) have cre-
ated a spectral database library for 109 reference strains
of yeast representing 44 species and eight genera to evalu-
ate the use of MALDI-TOF MS for the rapid identification
of yeast species. This library was challenged with 197 clin-
ical isolates. Three isolates gave no spectral score as no
reference spectrum were included in the database library.
Of the remaining 194 clinical isolates, 192 (99.0%) were
correctly identified at the species level and two organisms
gave consistently low spectral scores that could not be
identified. In summary, the use of MALDI-TOF MS for
the identification of clinically relevant yeasts is rapid and
accurate providing that the database is constructed with a
comprehensive collection of accurately identified reference
strains.
Filamentous fungi
Chen & Chen (2005) successfully identified several Peni-
cillium species directly from intact fungal spores mixed
with the MALDI matrix. Hettick et al. (2008b) have
achieved 100% correct identifications of 12 Penicillium
species by bead beating fungal samples resuspended in a
acetonitrile/trifluoroacetic acid solvent prior to MALDI-
TOF analysis. The observed mass spectra contained abun-
dant peaks in the range 5000–20 000 m/z allowing unam-
biguous discrimination between species. In addition, a
biomarker common to all Penicillium mass fingerprints
was observed at m/z of 13.9 kDa.
Using an extraction method similar to that used for Pen-
icillium species, Hettick et al. (2008a, b) obtained also
highly reproducible mass spectral fingerprints for 12 species
of Aspergillus and five strains of Aspergillus flavus. The 12
species were correctly identified but only a 95% accurate
identification was obtained at the strain level. It was also
pointed out that Aspergillus niger could not be distin-
guished from Aspergillus chevalieri. The authors concluded
that the identification of Aspergillus spp. with MALDI-TOF
MS would require a comprehensive database of at least 180
species of Aspergillus. A study showed that different species
of Aspergillus, including aflatoxigenic and nonaflatoxigenic
spp., could be characterized directly from intact spores (Li
et al., 2000). However, the authors reported certain dis-
crepancies due to the difficulties encountered to discrimi-
nate the spectra obtained with some of the analysed
species. A database including the reference spectra of 28
clinically relevant Aspergillus species was engineered in a
recent study by including species-specific fingerprints of
both young and mature colonies of reference strains (Ala-
nio et al., 2010). The performance of the database was
tested on 124 clinical and 16 environmental Aspergillus iso-
lates resulting in a 98.6% (138/140) correct identification
with 100% specificity (0% misidentification). This study
has demonstrated that a complete fingerprint database
including spectra from both young and mature fungal colo-
nies makes MALDI-TOF a robust method for Aspergillus
species identification regardless of the maturity of the
tested isolates.
The identification of multiple Fusarium spp. has also
been demonstrated by various studies. In the study by
Marinach-Patrice et al. (2009), 62 strains or isolates
belonging to nine Fusarium spp. were subjected to both
molecular identification and MALDI-TOF MS analysis.
Following updating of the BioTyper database with 13
strains of five Fusarium spp., 57 (92%) strains were cor-
rectly identified using MALDI-TOF MS analysis. Only one
Fusarium pseudonygamai isolate was misidentified and
four Fusarium isolates were not identified due to absence
of reference spectra in the database. MALDI-TOF MS was
also used successfully to identify five mycotoxin-producing
Fusarium spp. by direct analysis of spores which yiel-
ded highly reproducible MS profiles (Kemptner et al.,
2009).
Dermatophytes
The most important clinical fungal dermatophytes spe-
cies, T. rubrum, Trychophyton interdigitale, Trychophyton
tonsurans, and Arthroderma benhamiae, originating from
skin and nail were recently identified using the Saramis
database (Erhard et al., 2008). Except for one T. rubrum
strain, a high level of confidence (99.9%) was obtained in
this study where sufficient MS spectra were used to pro-
duce a super-spectrum for each species.
Problematic identifications
Similar to bacteria, absence of identification or misiden-
tification of fungal species by MALDI-TOF MS analysis
are essentially due to absence, mistakes or incomplete
reference spectra in the database (Table 2). High quality
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MS spectra are usually easily obtained with both fungal
hyphae and spores following the manufacturer’s instruc-
tion or based on the recommendation of reference stud-
ies. For instance, because of their cell wall structure,
yeasts need an extraction step to yield a valid score of
identification by MALDI-TOF MS. In the study of Bizzini
et al. (2010) only 4% (1/24) of the valid results were
obtained by direct application of the colony on the
MALDI plate and an extraction method prior to analysis
by MALDI-TOF was also shown to be mandatory to
obtain appropriate spectra in the study performed by van
Veen et al. (2010). The spectra of several Penicillium spp.
obtained from bead beating fungal samples resuspended
in an acidic solvent prior to MALDI-TOF analysis was
more discriminative (abundant peaks in the range 5000–
20 000 m/z) than spectra obtained directly from intact
spores (range of 2600–7378 m/z) (Chen & Chen, 2005;
Hettick et al., 2008a, b). However, Valentine et al. (2002)
identified A. niger, Rhizopus oryae, Trichoderma reesei,
and Phanerochaete chrysosporium using either intact
spores, hyphae or extracts showing that intact cells, soni-
cated cells, and acid-treated cells yielded similar spectra.
The main problem is that, unfortunately, very few ref-
erence spectra are currently included in the database of
commercially available MALDI-TOF MS systems. Most of
the studies showing that the MALDI-TOF MS identifica-
tion is a powerful system for the characterization and
identification of fungi have built and used their own ref-
erence spectra database and have developed their own
sample preparation techniques. There is thus still a lack
of standardized extraction protocols regarding filamen-
tous fungi.
In addition, the spectral signal of filamentous fungi
may be strongly influenced by the phenotype of the fun-
gus including basidiospore, monokaryon, dikaryon, fruit-
ing body, surface mycelium, strands and substrate
mycelium. Moreover, vegetative mycelium grown on agar
shows multiple zones that correspond to different ages or
developmental stages. These variations may thus influence
the spectral reproducibility of the same isolate and a
comprehensive database of filamentous fungi should
include MS fingerprints of several different developmental
forms to guarantee high yields and accuracy of identifica-
tion as demonstrated by Alanio et al. (2010).
Direct identification from samples
Given the accuracy of MALDI-TOF for bacterial identifi-
cation, this technology might be directly applied to
some clinical samples, such as blood, urine, cerebrospi-
nal fluid, pleural fluid, peritoneal liquid, and synovial
fluid. The major limitation is the amount of bacteria
present in the samples and the limit of detection of cur-
rent MALDI-TOF protocols. To circumvent this diffi-
culty, large volumes are used for blood and urine and
an additional enrichment by culture is available for
blood (see paragraphs below). Regarding cerebrospinal
fluid, Nyvang Hartmeyer et al. (2010) successfully identi-
fied S. pneumoniae 30 min after receiving a sample sup-
porting the proof-of-concept. However, practically,
bacterial identification from cerebrospinal fluid, strongly
limited by the low bacterial load and the limited volume
available, is yet not applicable in routine diagnostic lab-
oratories.
Blood (hemoculture)
Bloodstream infection, septic shock, and endocarditis rep-
resent severe diseases with important mortality and mor-
bidity. Blood culture represents the best way to establish
the etiology of such infections and to guide antimicrobial
treatment. This is important since rapid and appropriate
antimicrobial therapy is pivotal to reduce poor outcome
(Kollef, 2000). Indeed, the fatality rate was 20% for
bloodstream infection patients treated with appropriate
therapy and 34% for patients treated with inappropriate
therapy (Leibovici et al., 1998). The rapid notification of
the Gram stain result from positive blood culture has also
a positive impact for adaptation of antimicrobial regimen
(Munson et al., 2003). Consequently, the precise identifi-
cation of a microorganism isolated from positive blood
culture early after Gram stain notification will likely help
clinician to better adapt the antimicrobial therapy. As an
example, the impact on the choice of the antibiotic will
likely be significant when Gram-positive cocci are identi-
fied from blood cultures, as the antibiotic susceptibility
of Enterococcus faecium is clearly different from that of
alpha-hemolytic streptococci.
Quantitative blood cultures have demonstrated that bac-
terial load during bloodstream infection is very low in
adults, often < 1–10 colony forming unit mL1. In prac-
tice, blood samples are inoculated into bottles containing
broth media and incubated in automated instruments
monitoring CO2 concentrations released during bacterial
growth. At the automated growth detection time, the
bacterial load may reach a heavy growth up to 106–108
colony forming units mL1. In our laboratory, Enterobacte-
riaceae, P. aeruginosa, and aerobic Gram-positive cocci
were generally detected when present at 107 bacteria mL1.
Such bacterial concentration might be adequate to allow
accurate bacterial identification using MS.
However, the blood culture bottle fluid represent a
complex solution with multiple nonbacterial proteins iso-
lated from patient’s blood and nutrient growth media.
These proteins alter the specific bacterial MS profile
obtained by MALDI-TOF and have a detrimental effect
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on the performance of algorithm used to query the data-
base containing bacterial MS profiles.
The preparation of a bacterial pellet from positive
blood culture includes a differential centrifugation step to
discard blood cells, an erythrocyte lysis step and a subse-
quent washing step to remove additional nonbacterial
components. Application of this protocol allows the iden-
tification in < 1 h when compared with overnight growth
of bacteria required to obtain pure colonies for biochemi-
cal identification.
Recent studies (Table 3) have shown that a correct
identification by MALDI-TOF is obtained in > 80% of
cases starting from blood culture bottles. The results var-
ied according to the bacterial pellet preparation protocol
and the type of microorganism present in blood cultures.
Using ammonium chloride as lysing agent, 89% of Gram-
negative bacteria and 73% of Gram-positive bacteria (i.e.
90% for Staphylococci and 33% for Streptococci) were
correctly identified at the species level (Prod’hom et al.,
2010). No identification was observed in 21% of cases.
The lower performance of MALDI-TOF for Gram-posi-
tive bacteria and particularly Streptococci has also been
observed in other studies (Table 3). Similar to MALDI-
TOF identifications from pure microbial isolates, several
hypotheses have been suggested to explain discordant
results obtained from blood cultures: (1) the close
relatedness of the different species especially within Strep-
tococci, notably within S. mitis group (i.e. S. pneumoniae,
S. mitis, Streptococcus sanguinis, Streptococcus oralis) con-
ferring closely related MALDI-TOF spectrum profiles, (2)
the cell wall composition of Gram-positive bacteria con-
ferring resistance to lysis. In addition, the presence of
capsules in different species (S. pneumoniae, Haemophilus
influenzae, K. pneumoniae) may also explain the lower
performance of MALDI-TOF.
The performance of MALDI-TOF for the identification of
fungi in blood culture is low. In one study (Ferreira et al.,
2010c), no fungi (0/18) were identified at the species level
and only one at the genus level. This poor performance is
attributed to the relatively low load of fungi observed in
positive blood culture and to the presence of residual blood
protein which co-migrates during the MALDI-TOF assay,
which impairs the performance of the diagnostic algorithm.
To circumvent this detrimental effect, a reference database
of fungi obtained from blood culture spiked with fungi was
established to obtain correct identification at the species level
(Marinach-Patrice et al., 2010).
Limitation of the MALDI-TOF identification was also
observed for mixed bloodstream infection, where only
one bacterium could be identified (La Scola & Raoult,
2009; Moussaoui et al., 2010; Szabados et al., 2011).
The impact of the broth on the spectral quality and
thus on the rate of identification has been analysed in
several studies. The first published studies have used bot-
tles adapted to the BACTEC system (Becton Dickinson,
Franklin Lakes, NJ). More recently, bottles with and with-
out charcoal adapted to Bact/ALERT automated instru-
ments have been tested (bioMe´rieux). In this system,
charcoal is used to inactivate antimicrobial agents present
in the patient’s blood. In one study, the rate of identifica-
tion using MALDI-TOF was 30% without charcoal and
decreased to only 8% when charcoal was present (Szaba-
dos et al., 2011). Another study compared the perfor-
mance of identification using MALDI-TOF with positive
blood culture obtained from three automated systems:
BACTEC, VERSATREK (Trek Diagnostic Systems, Cleve-
land, OH) and BactT/ALERT. The rate of direct identifi-
cation of bacteria cultured in these three automated
blood culture devices were 76%, 69%, and 62% for the
investigated samples, respectively (Romero-Gomez &
Mingorance, 2011).
The importance of the protein extraction method was
compared with the so-called intact cell method, which
consist in the direct deposition on MALDI plate of bacte-
rial pellet obtained from positive blood culture. In one
study, the performance of MALDI-TOF identification at
the species level was 47% for the intact cell method com-
pared to 76% for the protein extraction method (Ferreira
et al., 2010a, b, c). The simple extraction method used in
this study improves significantly the performance of
MALDI-TOF identification rate. In our laboratory, we
now use this approach on a routine basis, with a turn-
around time estimated to be about 1 h. However, to be
efficient and have such a low turnaround time, there is a
need to prioritize identification of bacteria isolated from
blood cultures over other routine applications of the
MALDI-TOF. Thus, this activity somehow delays other
microbial identifications, as shown in Fig. 4.
In conclusion, the application of MALDI-TOF iden-
tification to microorganism pellets obtained from
positive blood culture allows a rapid identification of
microorganisms growing in blood culture which is
important for the management of bloodstream infections.
Urine
As the bacterial amount in urine taken from patients with
urinary tract infection is often  105 bacteria mL1, the
use of MALDI-TOF directly on urine has been investi-
gated by numerous groups. However, as only about
1–2 lL of liquid may be deposited on the MALDI-TOF
microplate, results were not accurate when untreated
urine are directly deposited and thus various pretreatment
steps have been tested with different outcomes. Using two
consecutive centrifugation steps (low speed to remove
leukocytes and high speed to collect the bacteria), Ferreira
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et al. (2010a, b, c) could accurately identify as much as
94.2% of bacteria. However, they only included in their
study urine with > 105 bacteria mL1. When investigating
a simplified protocol in our laboratory for the identifica-
tion of E. coli (single centrifugation step), the results was
acceptable when the bacterial concentration was of 107
and 108 bacteria mL1 with 69% and 70% of samples
being accurately identified at the species level (score > 2).
However, the yield was poor with lower bacterial load
(Fig. 5). Given the huge amount of urine processed on a
daily basis, the low value of early identification and the
requirement of bacterial isolation in pure culture for anti-
biotic susceptibility testing, it appears that the MALDI-
TOF on urine is not cost-effective and not efficient
enough to be implemented directly on urine samples.
Indeed, as most urinary isolates are E. coli (> 80% among
uncomplicated cystitis occurring in young women and
about 50% in complicated urinary tract infections), the
use of a chromogenic agar (i.e. Urid; bioMe´rieux) cou-
pled with simple phenotypic tests such as indole repre-
sents a simpler way to identify most strains. MALDI-TOF
will then be mainly used to identify the remaining species
starting from colonies.
Maintenance and quality controls
The MALDI-TOF MS is increasingly used in clinical diag-
nostic laboratory for microbial identification with reliable
results for bacterial identification at the species level.
MALDI-TOF results may, however, be impaired by
problems arising during extraction, for instance (1) when
testing encapsulated bacteria (S. pneumoniae, K. pneumo-
niae), (2) when testing bacteria such as Streptomyces, that
exhibit a particular cell wall that reduces the yield of pro-
tein extraction, (3) when the extraction protocol is not
properly conducted, or (4) when the reagents used for
extraction are outdated or impaired by inadequate stor-
age. Problems (1) and (2), due to intrinsic bacterial
properties, may only be circumvented by the development
of specific extraction protocols and problems (3) and (4)
might be prevented by an adequate quality program. The
performance of the extraction step and of the MALDI-
TOF mass spectrometer may be checked by routinely test-
ing a few selected bacterial strains, for which spectra are
available in the database. This control should ideally be
done in parallel with and without a specific extraction
step. We thus implemented in our laboratory routine
internal quality controls that test the quality of the
extraction step on two different bacterial species (E. coli
ATCC 25922 and S. aureus ATCC 25923). To set-up this
quality control, we first investigated the reproducibility of
the extraction step (see Fig. 2 and paragraph on repro-
ducibility). This allowed us to define conserved peaksTa
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(peaks present in 10/10 replicates). Then, we routinely
tested once a week both bacterial species. As score values
were always above 2 and to obtain a better expression of
the quality of the extraction, we decided to report the
proportion of conserved peaks detected, considering a
peak as present only when its intensity was above 200.
Indeed, the rate of detection of conserved peaks reflects
not only the quality of the sample but also the protein
yield and the spectral quality (Fig. 6).
MALDI-TOF results may also be impaired by inade-
quate deposit of the sample on the microplate and by
poor cleaning of the microplate between runs. Inadequate
deposit of samples is relatively rare when starting from
bacterial colonies and the learning curve is rapid with
most laboratory technicians being already experts in
depositing appropriate amount of bacteria after only a
few training days. However, erroneous identification may
occur due to well inversions, especially when large series
are processed and when stress is increased by human
resources shortage.
Poor cleaning of the microplate is a problem only
encountered by Bruker users as Shimadzu users will use
disposable MALDI-TOF plates. Bruker commonly propose
to use trichlorofluoroacteate (TFA) or guanidium to clean
microplates between usages. As TFA is associated with sig-
nificant occupational hazard (eye, skin, and respiratory
toxicity), we used in our laboratory an alternative protocol
to clean MALDI-TOF microplate. This protocol, initially
proposed by Bruker, which mainly uses ethanol and
mechanical cleaning of target plates, is, however, insuffi-
cient to properly clean MALDI-TOF microplates. Indeed,
when investigating cleaned plates by testing them only in
presence of matrix, we could obtain some accurate identifi-
cation with score > 2 and corresponding to the same bacte-
rial species investigated the day before. Such accurate
identifications obtained after plate cleaning could rarely
correspond to wells where some material was still present
(Fig. 7a, wells C4, E3, and E4), but also occurred in appar-
ently clean wells. Thus, a systematic control of the micro-
plates should be done and the cleaning protocol adapted
when necessary. Noteworthy, disposable microplates are
now also available for Bruker users.
MALDI-TOF results may also be impaired by technical
problems and/or poor maintenance of the MALDI-TOF
device. To identify possible technical problems and to re-
calibrate the MS apparatus, we routinely use in Lausanne
the calibration control proposed by Bruker. This control
08.00 h 09.00 h 10.00 h 11.00 h 12.00 h 13.00 h 14.00 h 15.00 h 16.00 h 
IM, P
ICU, S
BC
BC
BC
BC
U
U
Waiting time Matrix application MALDI-TOF analysis
Fig. 4. Importance of the organization of a working day to optimize time to results. Each line represents a MALDI-TOF run, with the waiting
time for equipment availability, the time required to prepare the target layout, and the time of the MALDI-TOF running process. In this example
of a working day, eight MALDI-TOF target plates have been used to analyse multiple clinical samples [ICU, S: intensive care unit and surgery (one
run); IM, P: internal medicine, pediatry and others (one target plate); BC: blood cultures (four runs); U: urine (two runs)]. Urgent samples such as
blood cultures are directly processed while colonies identification from agar cultures are processed by batch. The processing of the samples is
organized to guarantee the optimal use of the MALDI-TOF device during the working day.
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Fig. 5. Escherichia coli identification yield in urine samples. Five
milliliters of urine samples positive by microscopy were centrifuged to
concentrate and collect the bacteria. The pellet was resuspended in
200 lL water and subjected to protein extraction with ethanol and
formic acid prior deposition on the microplate. The graph shows the
identification yield according to the bacterial load per mL.
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(called BTS) consists of lyophilized E. coli extracts and
two supplementary proteins, RNAse A and myoglobin,
which respectively exhibit peaks at 13 683 and 16 952
m/z (Fig. 7b). Finally, in the future, external quality
control should be implemented.
Appropriate maintenance (Fig. S1) is also essential to
warrant accurate bacterial identification. Vacuum failure,
and thus MALDI-TOF MS functional disturbance (see
Fig. 1), might be observed due to the presence of dust
on plastic joints or to the aging of these plastic joints
(Fig. S1c and d). Dust exposure of the MALDI-TOF
apparatus might be reduced by placing the mass spec-
trometer in a quiet area, without drafts. Carbonization of
bacteria embedded in the matrix material following each
laser pulse is also a source of concern, as the laser source
may be soiled (Fig. S1d). With the Bruker instrument,
the level of dirt present on the laser source may be indi-
rectly estimated according to the number of shots needed
to obtain a correct identification. Maintenance should
ideally be done before the dirtiness rate reaches 80%, i.e.
about four times a year if three to five microplates are
tested per day. Of course, frequency of maintenance of
the MALDI-TOF should be increased if the apparatus is
heavily used or located in a crowded/dusty area.
Despite adequate maintenance and correct procedures,
some microbial groups will repeatedly be misidentified
due to poor content of some databases. Thus, it appears
critical not only to implement a quality control program
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(a)
(b) Fig. 6. Importance of the maintenance and
quality controls of the MALDI-TOF device
demonstrated by a follow-up of the temporal
reproducibility. (a) Spectral fingerprint of
Staphylococcus aureus quality controls during
a 10-week control period. (b) Percentage of
conserved peaks during a 10-week control
period. Escherichia coli and Staphylococcus
aureus quality controls fingerprints were
compared with a set of conserved peaks
(81 and 80, respectively). The poor
performance observed during week 1–3 was
likely caused by a problem of inadequate
sample deposition on the MALDI-TOF MS
microplates.
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targeting routine procedure but also to incrementally
improve the quality of the database. In conclusion, qual-
ity controls might help to improve the quality of proteins
extraction, MALDI-TOF analysis, and completeness of
databases. This will thus further improve the accuracy
and usefulness of MALDI-TOF.
Accuracy, time and cost effectiveness
The MALDI-TOF MS approach represents a new tool that
has the potential to replace conventional identification
techniques for a majority of routine isolates encountered
in clinical microbiology laboratories. The performance of
the MALDI-TOF MS approach has been compared in sev-
eral studies (Seng et al., 2009; Bizzini et al., 2010; Cherka-
oui et al., 2010; van Veen et al., 2010) with multiple
routine phenotypic identification methods, such as semi-
automated Gram staining (Aerospray Wescor®; Elitech),
catalase and oxidase determination tests, automated identi-
fication by Vitek® (bioMe´rieux), the Api Anae´robie
BioMe´rieux® identification strip for anaerobes (bioMe´rie-
ux), the Slidex Staph plus system (bioMe´rieux). These
studies showed that the MALDI-TOF technique has a high
accuracy for most microbial identifications and performed
equally as well as or better than conventional techniques.
For instance, van Veen et al. (2010) showed that signifi-
cantly more bacterial isolates could be identified to the
species level by MALDI-TOF MS, with a special higher
performance for staphylococci and bacteria from the HA-
CCEK group. Similarly, Bader et al. (2010) have shown
that identification of yeast species with MALDI-TOF MS
systems gave an overall species identification rate (97.9%
for Bruker and 96.1% for Shimadzu) that was comparable
with the one obtained with the biochemical tests (96.9%).
The most striking differences between MALDI-TOF
technique and conventional identification methods are
observed in the estimated time and costs required for
sample identification. The cost of bacterial identification
by MALDI-TOF MS was estimated to represent only 17–
32% (around €1.43/sample) of the costs of conventional
identification methods (around €4.6–8.23/sample) in the
study performed by Seng et al. (2009), which is sup-
ported by at least two other prospective studies (Bizzini
et al., 2010; Cherkaoui et al., 2010). Cherkaoui et al.
(2010) have shown that the reagents required for pheno-
typic identification using modern automated platforms
costs at least around $10 per isolate, whereas MS-required
reagents do not exceed $0.50. The expensive prices of MS
instruments are comparable with other common bacteri-
ology laboratory equipment such as automated blood cul-
ture and 16S sequencing devices but the running costs
are significantly cheaper than those of conventional iden-
tification methods. Thus, in our laboratory, we estimated
that the reagents costs spared during a year are of
approximately €40 000 (Table S2). Of course, this cost
analysis did not include the cost of maintenance, neither
for MALDI‐TOF nor for automated phenotypic identiﬁca-
tion systems such as Vitek.
Compared with conventional identification methods,
MALDI-TOF has been shown to confer in most cases a
significant gain of both technician working time (preana-
lytical procedure to prepare samples) and turnaround
time (automated analytical procedure to obtain results).
The time needed for bacterial identification from intact
cells was 6–8.5 min vs. 5–48 h for conventional identifi-
cation as estimated by Seng et al. (2009). When an
(a)
(b)
Fig. 7. Quality control for MALDI-TOF MS. (a) Presence of residual
materials on some wells (especially C4, E3, and E4, indicated by white
arrows) of a MALDI-TOF microplate after a routine wash, highlighting
the importance of careful wash after each usage; (b) mass spectra
obtained with the Bruker BST control, that consists in lyophilized
Escherichia coli spiked with RNAse A (black arrow at a m/z of 13 683)
and myoglobin (white arrow at a m/z of 16 952); in the lower part of
the panel, the list of the eight proteins that should be present to
validate the run and their expected and observed m/z values.
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extraction step is required, Bizzini et al. (2010) have esti-
mated that the extraction procedure for a single sample
takes approximately 6 min, a time per sample that is fur-
ther reduced during batch processing. The time effective-
ness gained with MALDI-TOF identification compared
with classical identification approaches is even more
accentuated when several isolates are analysed in parallel.
As reported by Cherkaoui et al. (2010) the analysis of 10
isolates in parallel can be accomplished in < 15 min with
limiting working time by MS, whereas more than
360 min would be required on an automated system with
more hands-on time for each isolate, demonstrating that
MALDI-TOF MS provide a reduction of both working
and turnaround times. Regarding yeast identification by
MALDI-TOF MS, Marklein et al. (2009) showed that this
technique required minimal time for technicians to pro-
cess yeast samples for analysis and to interpret the results.
The MALDI-TOF identification procedure from single
yeast colonies on the agar plate was generally completed
within 10 min per isolate and within 3 h for 96 samples.
In contrast, the identification of germ tube-negative Can-
dida species by phenotypic methods can require incuba-
tion periods of up to 72 h, a significantly longer
turnaround time compared with MALDI-TOF. Molecular
approaches have been or are currently under development
to provide efficient identification of yeasts with a more
rapid and reliable efficiency than classical phenotypic
methods. However, high-resolution DNA-based molecular
techniques such as 26S rRNA or internal transcriber
spacer DNA sequencing and real-time PCR assays are
expensive and time-consuming and appear in most cases
less convenient than MALDI-TOF MS for routine labora-
tory identifications (Schabereiter-Gurtner et al., 2007;
Montero et al., 2008; Seyfarth et al., 2008). Nucleic acid-
based identification strategies suffer problematic limita-
tions in terms of (1) technical problems (inhibitory com-
pounds, contamination, separate areas for sample
preparation/amplification/analysis), (2) reagent and labor
costs, (3) spectrum of species identification in a single
assay often limited to a few individual species, and (4)
much longer turnaround time than MS. Thus such
lengthier, costlier and more labor-intensive alternatives to
MALDI-TOF MS are usually reserved for the identifica-
tion of the small minority of isolates not identified by
MS alone or by other conventional phenotypic and/or
biochemical identification approaches.
Taxonomy and microbial typing
Taxonomic usefulness of MALDI-TOF MS
Taxonomy is the systematic classification of organisms
based on their phenotypic, genetic and phylogenetic char-
acteristics. Thus, various phenotypic approaches (mor-
phology, biochemical reactions, and sugar assimilation)
have been used by microbiologists to classify microorgan-
isms. However, genome analysis through sequencing of
bacterial genes or of the entire genome currently repre-
sents the gold-standard of microbial taxonomy, although
it should always be confronted to phenotypic traits in a
polyphasic approach. MALDI-TOF MS represents an
additional approach to classify microorganisms based on
phenotypic traits. As previously shown in several studies
mentioned in this review, MALDI-TOF MS systems give
accurate and reproducible results at the species level that
are in most cases concordant with genomic identification
methods and consequently, MALDI-TOF has the poten-
tial to be used in polyphasic taxonomy. For instance, in
contrast to housekeeping genes sequencing such as
16SrRNA that provide taxonomical data on a single gene
at a time, MALDI-TOF MS fingerprints provide informa-
tion about multiple protein components that characterize
a microorganism. In addition, MALDI-TOF fingerprints
provide data of both the presence (conservation/diver-
gence) and the intensity (expression level) that together
compose a two dimensional taxonomical asset which offer
a better discriminative resolution for microorganism clas-
sification.
Microbial typing and identification at the
subspecies level
MALDI-TOF MS allows identification of microorganisms
at the species level and sometimes at the subspecies
level but several studies have shown that the requirements
for MALDI-TOF MS-dependent microbial typing are
different and more complex than those required for rou-
tine microbial identification. This is a challenge for clini-
cal laboratories that want to use MALDI-TOF MS for
routine strain typing. Relatively few biomarkers (5–10
peaks) are usually required for the identification of
microbial isolates at the species level, whereas a much lar-
ger number of reproducible peaks is needed for subspe-
cies identification (Dieckmann et al., 2008). Many studies
cited in this review using conventional MALDI-TOF pro-
cedure could not directly identify taxonomic entities like
species or subspecies with an accuracy of 100% without
the assistance of DNA-based methods. Microbial typing
and thus microbial characterization at the subspecies level
required very different sample preparation and analytical
procedures (Murray, 2010). As mentioned previously in
this review, accurate sample preparation is generally
unnecessary for microorganism identification but for
strain typing and subspecies identification, a rigorous
optimization of testing parameters appears to be crucial.
The challenge is to obtain a sufficient number of repro-
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ducible markers with specificities below species-level spec-
ificity (Rupf et al., 2005; Vargha et al., 2006; Dieckmann
et al., 2008). For instance, the sample preparation proce-
dure (whole cell or protein extraction), the protein con-
centration, the type of matrix, the sample : matrix ratio,
the concentration of acid added to the matrix and the
growth medium are examples of technical parameters that
can have a significant influence on the MALDI-TOF spec-
tral profile of biomarkers (Vargha et al., 2006; Dieck-
mann et al., 2008).
The choice of analysis solutions used to process mass
spectra can have a significant impact on the power of dis-
crimination and thus on the ability to distinguish closely
related isolates. Maximizing reproducibility is also critical
for accurate microbial characterization. One of the major
limitations of MALDI-TOF-based microbial typing is pri-
marily due to the algorithmic methods used to analyse
the protein profiles. Several similarity coefficients can be
used to determinate level of similarities. Some account
only for peak presence/absence such as the Dice similarity
coefficient, whereas others take also in consideration the
peak intensities, such as cosine and Pearson product-
moment correlation coefficients. The chosen similarity
coefficient affects the reproducibility and the discrimina-
tory power of the method. Several studies have demon-
strated that the Pearson coefficient appears to be more
adequate for the correct classification of microbial iso-
lates. A study by Giebel et al. (2008) showed that the
Pearson product-moment correlation coefficient permit-
ted a more accurate classification of Enterococcus spp. iso-
lates than the Dice similarity coefficient. Similarly, the use
of the Pearson correlation coefficient allowed a 28%
increase in the rate of correct classification of E. coli iso-
lates (Giebel et al., 2010). Using optimal sample prepara-
tion and MALDI conditions for discrimination at the
strain level and by using the Pearson coefficient, Vargha
et al. (2006) have shown that MALDI-TOF MS offered a
better discriminatory power than 16S rRNA gene sequenc-
ing for the classification at the subspecies level of Arthro-
bacter isolates. For instance, members of the A. globiformis
cluster have 99–100% sequence similarity, whereas
MALDI-TOF MS similarity is 60–95%.
In some cases, the identification of multiple or single
unique subspecies biomarkers have been used to discrimi-
nate closely related microbial isolates exhibiting highly
similar mass signatures. For instance, five unique and
conserved biomarkers ions were identified in environ-
mental E. coli isolates from avian but not from human
sources (Siegrist et al., 2007). Similarly, several Listeria
monocytogenes serotypes could be separated using dis-
criminating peaks (Barbuddhe et al., 2008).
Despite an increased level of complexity required for
microbial subspecies classification, several published stud-
ies support the observation that MALDI-TOF MS repre-
sents a new promising technological approach for the
classification of clinical and environmental isolates. Die-
ckmann et al. (2008) have successfully classified 126 iso-
lates of Salmonella at the species and subspecies levels by
optimizing a procedure that allowed them to obtain more
than 300 biomarker peaks ranging from 2 to > 35 kDa.
They found that out of three matrix mixtures, SA pro-
duced the most informative spectra by providing a signif-
icant increase of high molecular mass peaks with
important subspecies specificity. In addition, simple clus-
tering of mass data from bacterial fingerprints did not
initially provide a clear discrimination of the strains at
the subspecies level and a bioinformatic approach recently
published by Teramoto et al. (2007) had to be used. The
approach is a new phylogenetic classification method
based on ribosomal protein profiling by MALDI-TOF MS
using the bioinformatics-based method for rapid identifi-
cation of bacteria published by Demirev et al. (1999).
Using this approach, the result of the classification of sev-
eral P. putida strains including different biovars was in
agreement with the gyrB gene sequences-based classifica-
tion.
The determination of serotypes of Shiga toxin-produc-
ing E. coli isolates has been achieved by constructing pro-
totype spectra representing different serotype groups
(Karger et al., 2011). The prototype spectra were gener-
ated by removing masses with low discriminative signifi-
cance, which is a process comparable with the generation
of super-spectra proposed by the Saramis software. The
generation of prototype spectra allowed a reduction of
incorrect assignments down to 0.7% compared to the
31% incorrect assignments observed when unfiltered mass
spectra were used. Unlike restriction fragment length
polymorphism analysis, this analytical methodology could
not achieve a differentiation below the serotype level.
The typing of several microorganisms, such as Staphy-
lococcus and Listeria species, for epidemiological studies
require the use of various conventional techniques such
as pulsed-field gel electrophoresis (PFGE), amplified frag-
ment length polymorphism analysis and multilocus
sequence analysis (MLSA). These gold-standard tech-
niques provide accurate classification of microorganism
but suffer from important time and cost investments. For
instance, only a few hours are required to obtain results
by MALDI-TOF MS whereas several days are necessary to
collect PFGE data. In addition, these methods are techni-
cally relatively complex and have to be usually performed
by experienced technicians.
Several Staphylococcus studies have developed standard-
ized methods to achieve reliable and reproducible species
level identification and sub-typing from MALDI-TOF fin-
gerprints (Edwards-Jones et al., 2000; Walker et al., 2002;
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Jackson et al., 2005). When performed under careful exper-
imental conditions, MALDI-TOF MS has been used to dis-
criminate between methicillin-resistant (MRSA) and
methicillin-susceptible S. aureus strains and to subtype
MRSA strains. Thus, compared with conventional antimi-
crobial susceptibility test methods or gene sequencing tech-
niques, these studies have demonstrated that MALDI-TOF
MS represents a fast and cheap approach to accurately dif-
ferentiate S. aureus strains. Unfortunately, no comparison
of MALDI-TOF MS with PFGE has been performed to
demonstrate that these two methods would give similar
results. However, Barbuddhe et al. (2008) have used
MALDI-TOF to accurately identify 146 strains of different
Listeria species and correctly classified all L. monocytogenes
serotypes in agreement with PFGE, which is one of
the most common subtyping techniques used to classify
L. monocytogenes serotypes. Similarly, Fujinami et al.
(2010) have demonstrated that MALDI-TOF MS and PFGE
gave similar accurate identification of epidemiologic Legio-
nella strains. Hazen et al. (2009) have demonstrated that
MALDI-TOF MS could be used to discriminate between
several Vibrio parahaemolyticus strains in replacement of
PFGE or MLSA. Thus, these studies showed that MALDI-
TOF represents a new promising alternative approach to
other demanding conventional methods such as PFGE and
MLSA for microbial subtyping.
Overall, the ultimate goal would be to use MALDI-
TOF for a rapid prospective typing at the time of identi-
fication, which should significantly benefit to hospital
epidemiology and to infection control measures that have
to be applied to prevent dissemination of pathogens.
Three recent studies have demonstrated that by applying
subtle minor changes in the set-up generally used in rou-
tine diagnostics, MALDI-TOF MS allowed a reproducible
discrimination of major MRSA lineages (Wolters et al.,
2011), an identification of Salmonella enterica subsp.
enterica serovars (Dieckmann & Malorny, 2011) and a
differentiation between cfiA-negative and cfiA-positive
Bacteroidis fragilis isolates (Wybo et al., 2011). These
studies demonstrate that for several microbial species,
minor changes in standardized procedures such as
improved algorithm and user-friendly softwares applied
in routine diagnostics will allow the use of MALDI-TOF
MS for rapid and inexpensive microbial typing. This
could significantly improve the approaches currently used
to monitor epidemiological outbreaks and pathogen
surveillance.
Conclusion
MALDI-TOF represents a very appealing new microbial
identification technology that is efficient, rapid, cheap,
and easy to use. This explains why MALDI-TOF MS can
be successfully used in clinical diagnostic laboratory for
microbial identification starting from subcultures on agar
plates and broth media but also directly from positive
blood cultures and to a lesser extent from clinical samples
such as urine. The application of MALDI-TOF at the
subspecies level in typing is promising but still needs fur-
ther improvement including instrument sensitivity, data-
base quality, and postrun analysis methods. Overall, a
MALDI-TOF MS will be soon present in most diagnostic
laboratories as, despite the significant cost of the instru-
ment and for maintenance, running costs and consum-
ables are much lower than those for other conventional
methods, rendering this technology a worthy quantum
leap tool.
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